EyePoint Pharmaceuticals (EYPT) Insider Trading & Ownership → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free EYPT Stock Alerts $16.47 -1.10 (-6.26%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media EyePoint Pharmaceuticals (NASDAQ:EYPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.05%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$79.41 MNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$49.30 M Get EYPT Insider Trade Alerts Want to know when executives and insiders are buying or selling EyePoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EYPT Insider Buying and Selling by Quarter Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW EyePoint Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/18/2024Cormorant Asset Management, LpMajor ShareholderBuy581,765$18.03$10,489,222.95 2/2/2024David Scott JonesSVPSell209$28.49$5,954.41 1/26/2024Dario A PaggiarinoInsiderSell49,325$25.66$1,265,679.50 1/25/2024David Scott JonesSVPSell600$25.00$15,000.00 1/23/2024Dario A PaggiarinoInsiderSell5,135$25.00$128,375.00 1/23/2024David Scott JonesSVPSell900$25.00$22,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/11/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.75$14,812,500.00 1/11/2024Ye LiuDirectorSell1,910,500$19.45$37,159,225.00 1/9/2024Cormorant Asset Management, LpMajor ShareholderBuy105,000$21.32$2,238,600.00 1/8/2024Dario A PaggiarinoInsiderSell22,913$21.13$484,151.69 12/13/2023Dario A PaggiarinoInsiderSell1,458$20.00$29,160.00 12/8/2023Cormorant Asset Management, LpMajor ShareholderBuy588,235$17.00$9,999,995.00 12/6/2023Ye LiuDirectorSell266,242$18.41$4,901,515.22 12/4/2023Cormorant Asset Management, LpMajor ShareholderBuy1,919,057$21.82$41,873,823.74 12/4/2023Michael Craig PineInsiderSell45,000$22.00$990,000.00 9/1/2023Ew Healthcare Partners, L.P.Major ShareholderSell20,000$9.90$198,000.00 8/30/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,976$10.92$665,857.92 8/28/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,858$11.71$712,647.18 8/24/2023Ew Healthcare Partners, L.P.Major ShareholderSell139,280$14.62$2,036,273.60 8/22/2023Ew Healthcare Partners, L.P.Major ShareholderSell46,778$14.62$683,894.36 5/30/2023Ye LiuDirectorSell1$6.00$6.00 (Data available from 1/1/2013 forward) EYPT Insider Trading Activity - Frequently Asked Questions Who is on EyePoint Pharmaceuticals's Insider Roster? The list of insiders at EyePoint Pharmaceuticals includes Cormorant Asset Management, Lp, Dario A Paggiarino, David Scott Jones, Ew Healthcare Partners, L.P., Michael Craig Pine, and Ye Liu. Learn more on insiders at EYPT. What percentage of EyePoint Pharmaceuticals stock is owned by insiders? 13.05% of EyePoint Pharmaceuticals stock is owned by insiders. Learn more on EYPT's insider holdings. Which EyePoint Pharmaceuticals insiders have been buying company stock? The following insider purchased EYPT shares in the last 24 months: Cormorant Asset Management, Lp ($79,414,141.69). How much insider buying is happening at EyePoint Pharmaceuticals? Insiders have purchased a total of 3,944,057 EYPT shares in the last 24 months for a total of $79,414,141.69 bought. Which EyePoint Pharmaceuticals insiders have been selling company stock? The following insiders have sold EYPT shares in the last 24 months: Dario A Paggiarino ($1,907,366.19), David Scott Jones ($43,454.41), Ew Healthcare Partners, L.P. ($4,296,673.06), Michael Craig Pine ($990,000.00), and Ye Liu ($42,060,746.22). How much insider selling is happening at EyePoint Pharmaceuticals? Insiders have sold a total of 2,630,175 EyePoint Pharmaceuticals shares in the last 24 months for a total of $49,298,239.88 sold. More Insider Trading Tools from MarketBeat Related Companies: CTKB Insider Trades LAB Insider Trades QTRX Insider Trades PACB Insider Trades NAUT Insider Trades HBIO Insider Trades BNGO Insider Trades AXDX Insider Trades TXG Insider Trades IMNM Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:EYPT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
